Beleave Inc. (BLEVF)
OTCMKTS
· Delayed Price · Currency is USD
0.0000
0.00 (0.00%)
At close: Apr 24, 2025
Beleave Revenue
Beleave had revenue of 381.94K CAD in the quarter ending December 31, 2019, a decrease of -52.66%. This brings the company's revenue in the last twelve months to 2.90M, up 117.74% year-over-year. In the fiscal year ending March 31, 2019, Beleave had annual revenue of 2.37M.
Revenue (ttm)
2.90M CAD
Revenue Growth
+117.74%
P/S Ratio
0.00
Revenue / Employee
n/a
Employees
n/a
Market Cap
554.00 USD
Revenue Chart
* This company reports financials in CAD.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Endo Inc. | 1.76B |
| Veradigm | 588.02M |
| Glass House Brands | 200.90M |
| Elite Pharmaceuticals | 70.00M |
| Northwest Biotherapeutics | 1.38M |
| BioStem Technologies | 301.83M |
| American Oncology Network | 1.76B |
| Silence Therapeutics | 43.26M |